ArticleFrontiers in pharmacology2021

Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab.

Yutong Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.